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Nomenclature 
 
Original Swissmodel homology models were numbered 1-8. However due to redundancy 
monomer Models 1,2,4,6,7,8 were taken through to refinement. Model 8 was only obtained 
as a monomer, so just 5 models were refined as their homodimers. For clarity and to define 
their point of origin, these were named Models11,12,14,16,17&18. 
 
E.g.: 
 
Raw Model PDB Template Refined monomer model Refined dimer model 
1 (dimer) 2z9j 
 
Model 1 Model 11 
2 (dimer) 3vb3 Model 2 Model 12 
3 (dimer) 2z9j   
4 (dimer) 1uk3 Model 4 Model 14 
5 (dimer) 1uk3   
6 (dimer) 2a5i Model 6 Model 16 
7 (dimer) 1uj1 Model 7 Model 17 
8 (monomer) 1z1i Model 8  
 
Table S1. Naming system used for the models at each stage of refinement. 
  
 2 
#======================================= 
# 
# Aligned_sequences: 2 
# 1: WH-Human_1pr 
# 2: BatHKU4_pr (2ynb) 
# Matrix: EBLOSUM62 
# Gap_penalty: 10.0 
# Extend_penalty: 0.5 
# 
# Length: 314 
# Identity:     154/314 (49.0%) 
# Similarity:   203/314 (64.6%) 
# Gaps:          16/314 ( 5.1%) 
# Score: 789.0 
# 
#======================================= 
 
WH-Human_1pr       1 SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDML     50 
                     ||..||:.|||.||.|:||||||:.||||||||:.|:||||::|.::.:. 
BatHKU4_pr         1 SGLVKMSAPSGAVENCIVQVTCGSMTLNGLWLDNTVWCPRHIMCPADQLT     50 
 
WH-Human_1pr      51 NPNYEDLLIRKSNHNFLVQ---AGNVQLRVIGHSMQNCVLKLKVDTANPK     97 
                     :|||:.|||.|:||:|:||   .....|||:.|||...:|||.||.|||. 
BatHKU4_pr        51 DPNYDALLISKTNHSFIVQKHIGAQANLRVVAHSMVGVLLKLTVDVANPS    100 
 
WH-Human_1pr      98 TPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGS    147 
                     ||.|.|..::||.:|||||||||.|:||:...:|.|.|||||||.||||| 
BatHKU4_pr       101 TPAYTFSTVKPGASFSVLACYNGKPTGVFTVNLRHNSTIKGSFLCGSCGS    150 
 
WH-Human_1pr     148 VGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTD    197 
                     ||:..:...::|.|||.|||..|.|.|:..:|..||.|.|:||.|...|| 
BatHKU4_pr       151 VGYTENGGVINFVYMHQMELSNGTHTGSSFDGVMYGAFEDKQTHQLQLTD    200 
 
WH-Human_1pr     198 TTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHV    247 
                     ...|:||:|||||||:||.:||:......:       :.||...|:.... 
BatHKU4_pr       201 KYCTINVVAWLYAAVLNGCKWFVKPTRVGI-------VTYNEWALSNQFT    243 
 
WH-Human_1pr     248 DILGP-----LSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFT    292 
                     :.:|.     |:.:||::|..|.|:::. |..|..|:||||.:.|||||| 
SEQUENCE         244 EFVGTQSIDMLAHRTGVSVEQMLAAIQS-LHAGFQGKTILGQSTLEDEFT    292 
 
WH-Human_1pr     293 PFDVVRQCSGVTFQ    306 
                     |.||..|..||..| 
BatHKU4_pr       293 PDDVNMQVMGVVMQ    306 
 
Figure S1. EMBOSS Needle alignment of the extracted protease sequence of Wuhan 
coronavirus against Bat coronavirus (PDB:2YNB) Catalytic dyads (His41, Cys145) shown in 
red bold. 	  
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#======================================= 
# 
# Aligned_sequences: 2 
# 1: WH-Human_1pr 
# 2: SARS_pr (2z9j_A) 
# Matrix: EBLOSUM62 
# Gap_penalty: 10.0 
# Extend_penalty: 0.5 
# 
# Length: 306 
# Identity:     294/306 (96.1%) 
# Similarity:   302/306 (98.7%) 
# Gaps:           0/306 ( 0.0%) 
# Score: 1600.0 
# 
#======================================= 
 
WH-Human_1pr       1 SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDML     50 
                     ||||||||||||||||||||||||||||||||||.||||||||||:|||| 
SARS_pr            1 SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDTVYCPRHVICTAEDML     50 
 
WH-Human_1pr      51 NPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPK    100 
                     ||||||||||||||:||||||||||||||||||||:|:|||||:|||||| 
SARS_pr           51 NPNYEDLLIRKSNHSFLVQAGNVQLRVIGHSMQNCLLRLKVDTSNPKTPK    100 
 
WH-Human_1pr     101 YKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGF    150 
                     |||||||||||||||||||||||||||||||||.|||||||||||||||| 
SARS_pr          101 YKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNHTIKGSFLNGSCGSVGF    150 
 
WH-Human_1pr     151 NIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTI    200 
                     |||||||||||||||||||||||||||||.|||||||||||||||||||| 
SARS_pr          151 NIDYDCVSFCYMHHMELPTGVHAGTDLEGKFYGPFVDRQTAQAAGTDTTI    200 
 
WH-Human_1pr     201 TVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDIL    250 
                     |:|||||||||||||||||||||||||||||||||||||||||||||||| 
SARS_pr          201 TLNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDIL    250 
 
WH-Human_1pr     251 GPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQC    300 
                     ||||||||||||||||:|||||||||||||||||.:|||||||||||||| 
SARS_pr          251 GPLSAQTGIAVLDMCAALKELLQNGMNGRTILGSTILEDEFTPFDVVRQC    300 
 
WH-Human_1pr     301 SGVTFQ    306 
                     |||||| 
SARS_pr          301 SGVTFQ    306 
 
Figure S2. EMBOSS Needle alignment of the extracted protease sequence of Wuhan 
coronavirus against SARS coronavirus (PDB: 2z9j) Catalytic dyads shown in red bold. 
 
MolProbity scoring and statistics for refined monomer models 1,2,4,6,7,8 and dimer 
models 
 
Monomer models. 
 
Model Template 
name 
Ramachandran 
favoured (%) 
Ramachandran 
allowed (%) 
Clashscore 
(percentile) 
MolProbity 
score 
(percentile) 
CA 
Geometry 
outliers 
(%) 
Cβ 
deviations 
(%) 
1 2z9j.1.B 96.33 100 1.52 (99th) 1.36 (98th) 0.0 0.0 
2 3vb3.1.A 96.66 100 1.30 (99th) 1.12 (100th) 0.0 0.0 
4 1uk3.1.B 93.98 99.67 1.52 (99th) 1.74 (88th) 0 0 
6 2a5i.1.A 96.38 99.67 0.63 (99th) 0.95 (100th) 0 0 
7 1uj1.1.B 96.66 99.67 1.52 (99th) 1.43 (96th) 0 0 
8 1z1i.1.A 91.30 99.33 3.04 (98th) 2.02 (75th) 0.34 0.36 
 
Table S2. Statistics via MolProbity with no His/Asn/Gln flips allowed. 
 4 
Model Template 
name 
Ramachandran 
favoured (%) 
Ramachandran 
allowed (%) 
Clashscore 
(percentile) 
MolProbity 
score 
(percentile) 
CA 
Geometry 
outliers 
(%) 
Cβ 
deviations 
(%) 
1 (1 
flip) 
2z9j.1.B 96.33 100 1.30 (99th) 1.32 (98th) 0.0 0.0 
2 (2 
flips) 
3vb3.1.A 96.66 100 1.30 (99th) 1.12 (100th) 0.0 0.0 
4 (0 
flips) 
1uk3.1.B 93.98 99.67 1.52 (99th) 1.74 (88th) 0 0 
6 (2 
flips) 
2a5i.1.A 96.38 99.67 0.63 (99th) 0.95 (100th) 0 0 
7 (1 
flip) 
1uj1.1.B 96.66 99.67 1.52 (99th) 1.43 (96th) 0 0 
8 (3 
flips) 
1z1i.1.A 91.30 99.33 3.04 (98th) 2.02 (75th) 0.34 0.36 
 
Table S3. Statistics via MolProbity with His/Asn/Gln flips allowed. 5/6 models had the 
possibility of suggested hydrogen bonding flips, but only the top model1 resulted in any 
improvement to the clash and MolProbity scores. 
 
Dimer models: 
 
Dimer Template 
name 
Ramachandran 
favoured (%) 
Ramachandran 
allowed (%) 
Clashscore 
(percentile) 
MolProbity 
score 
(percentile) 
CA 
Geometry 
outliers 
(%) 
Cβ 
deviations 
(%) 
11 2z9j.1.B 96.51 99.83 1.62 (99th) 1.41 (97th) 0.17 0.0 
12 3vb3.1.A 96.35 100 1.18 (99th) 1.12 (100th) 0.0 0.0 
14 1uk3.1.B 94.16 99.67 1.84 (99th) 1.73 (88th) 0.34 0 
16 2a5i.1.A 95.72 99.67 0.73 (99th) 1.03 (100th) 0 0 
17 1uj1.1.B 94.82 99.83 1.30 (99th) 1.58 (93rd) 0 0.18 
 
Table S4. Statistics via MolProbity with no His/Asn/Gln flips allowed. 
 
 
Dimer Template 
name 
Ramachandran 
favoured (%) 
Ramachandran 
allowed (%) 
Clashscore 
(percentile) 
MolProbity 
score 
(percentile) 
CA 
Geometry 
outliers 
(%) 
Cβ 
deviations 
(%) 
11 (2 
flips) 
2z9j.1.B 96.51 99.83 1.51 (99th) 1.40 (97th) 0.17 0.0 
12 (4 
flips) 
3vb3.1.A 96.35 100 1.18 (99th) 1.12 (100th) 0.0 0.0 
14 (1 
flip) 
1uk3.1.B 94.16 99.67 1.84 (99th) 1.73 (88th) 0.34 0 
16 (4 
flips) 
2a5i.1.A 95.72 99.67 0.73 (99th) 1.03 (100th) 0 0 
17 (3 
flips) 
1uj1.1.B 94.82 99.83 1.30 (99th) 1.58 (93rd) 0 0.18 
 
Table S5. Statistics via MolProbity with His/Asn/Gln flips allowed. 
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Figure S2. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model1 
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Figure S3. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model2 
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Figure S4. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model4 
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Figure S5. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model6 
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Figure S6. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model7 
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Figure S7. Ramachandran plots for Wuhan CoV 3CLpro homology monomer model8 
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Figure S8. Ramachandran plots for Wuhan CoV 3CLpro homology dimer model11 
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Figure S9. Ramachandran plots for Wuhan CoV 3CLpro homology dimer model12 
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Figure S10. Ramachandran plots for Wuhan CoV 3CLpro homology dimer model14 
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Figure S11. Ramachandran plots for Wuhan CoV 3CLpro homology dimer model16 
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Figure S12. Ramachandran plots for Wuhan CoV 3CLpro homology dimer model17  
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Molecular Dynamics Method 
 
Molecular dynamics simulations were performed with the Desmond Molecular Dynamics 
System (D. E. Shaw Research, New York, NY) by using the tools incorporated in the 
Schrödinger Suite 2019-2. The model system was set up by using the “System Setup” utility. 
The OPLS2005 force field parameters were implemented during simulations. Each monomer, 
dimer or ternary complex was placed in an orthorhombic box with solvent buffers up to 10Å 
along each dimension. The TIP3P solvent model was used to describe water molecules. 
Overall neutralisation of the system was achieved by adding sodium and chloride ions at the 
physiological concentration of 0.15M. The prepared model systems were then relaxed by 
using the multi-step default protocol in Desmond. After relaxation, the whole system was 
subjected to a 100ns simulation. The cut-off distance for computing short-range electrostatics 
and Lennard–Jones interaction was set to 9.0Å. The trajectories and energies were recorded 
every 100 and 1.2ps, respectively. MD simulations were performed at the IMB cluster from 
the University of Queensland on NVIDIA P100 GPUs or on a CentOS Linux Desktop with a 
Quadro RTX 5000 GPU. Simulation analysis was performed on Linux or Macintosh desktops 
using the Simulation Interactions Diagrams module in Schrödinger Suite 2019-2. 
 
 
 
Model2 from SARS 3vb3 WH_human_protease_from3vb3_Minimised.pdb 
 
Figure S1-13. Protein C-alpha RMSD over the 100 ns duration molecular dynamics 
simulation. Figure S1-14. Protein C-alpha RMSF plot. Per residue variability in Ca position. 
 
Flexible residues  
 
Figure S1-15. WH CoV 3CLpro Model 2 shown as green ribbons, except catalytic dyad 
(His41, Cys145 – yellow sticks), and magenta ribbons for regions found to be mobile in 100 
ns MD simulation.  
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Moderately mobile regions (>1.5 RMSF) N-terminal residues Ser1-Phe3, b-hairpin loop 
Gly23-Thr25, a-helix and loop Thr45-Arg60, loop tip Asn72, strand Gly138-Gly143, b-
hairpin loop Pro168-Gly170, long strand Gln189-Gly195, strand Asn274-Gly278, C-terminus 
Gln299-Ser301. 
 
 
Model6 from SARS 2a5i WH_human_protease_from2a5i_Minimised.pdb 
 
Figure S1-16. Protein C-alpha (blue line) and ligand (red line) RMSD over the 100 ns 
duration MD run. Figure S1-17 Protein RMSF plot. Per residue variability in Ca position. 
Figure S1-18. Protein- ligand interaction summary diagram. Orange: negative charge 
interaction, blue: polar interactions, green: hydrophobic interactions, grey circles: solvent 
exposed atoms. 
 
Over the first 10 ns of the simulation the mobile loop 44CTSEDMLNPN53 defining the 
boundary of the S2 subsite moves away from the bound ligand, and remains distant during 
the remaining 80ns.  
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Flexible residues  
 
 
Figure S1-19. WH CoV 3CLpro Model 6 shown as green ribbons, except catalytic dyad 
(His41, Cys145 – yellow sticks), and magenta ribbons for regions found to be mobile in the 
100 ns molecular dynamics simulation. Covalently bound SARS inhibitor carried through in 
model from template PDB:2a5i shown as grey sticks.  
 
Moderately mobile regions (>1.5 RMSD) N-terminal residues Ser1-Gly2, b-hairpin loop 
Gly23-Thr25, very mobile a-helix and loop Thr45-Arg60, loop tip Asn72, long strand 
Arg188-Ala194, strand Arg222-Thr224, strand Asn274-Arg279, C-terminus Ser301-Gln306. 
 
 
Model12 from SARS 3vb3 WH_human_protease_from3vb3_dimerMinimised.pdb 
 
Figure S1-20. Protein C-alpha (blue line) RMSD over the 100 ns duration MD run. Figure 
S1-21. Protein RMSF plot. Per residue variability in Ca position. 
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Flexible residues 
  
 
Figure S1-21. WH CoV 3CLpro Model 12 Chain A shown as green ribbons, Chain B cyan 
ribbons, except catalytic dyads (His41, Cys145 – green and cyan sticks), and magenta 
ribbons for regions found to be mobile in 100 ns MD simulation.  
 
In comparison to the MD simulation of the monomer (Model 2), the dimer shows stable N- 
and C-termini for both subunits, as these form part of the dimer interface which remains quite 
stable during the simulation. The very mobile helix and loop region show slight differences in 
mobility (Chain A Ser46-Ser62, Chain B Thr45-Asp56). In addition there are differences in 
the N-terminal domains, the Chain B helices Leu227-Met235 and Glu270-Met276 being 
slightly more mobile than those in Chain A. 
 
Moderately mobile regions (>1.5 RMSD) Chain A: a-helix and loop Ser46-Ser62, loop tip 
Asn72, long strand 215-Thr225, helical turn Thr243-His246, large loop Asn274-Arg279, C-
terminus Ser301. Chain B: b-hairpin loop Gly23-Thr25, a-helix and loop Thr45-Asp56, loop 
tip Asn72, loop Pro168-Gly170, long strand and helix Trp218-Met235, loop Thr243-Gln244, 
loop and helical turn Glu270-Thr280, loop Gly283-Leu286. 
 
Model16 from SARS 2a5i WH_human_protease_from2a5i_dimerMinimised.pdb 
 
Figure S1-22. Protein C-alpha (blue line) and ligand (red line) RMSD over the 100 ns 
duration MD run. Figure S1-23. Protein RMSF plot. Per residue variability in Ca position. 
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Figure S1-24. Protein- ligand interaction summary diagram. Orange: negative charge 
interaction, blue: polar interactions, green: hydrophobic interactions, grey circles: solvent 
exposed atoms. 
 
Flexible residues  
 
 
Figure S1-14. WH CoV 3CLpro Model 16 Chain A shown as green ribbons, Chain B cyan 
ribbons, except catalytic dyads (His41, Cys145 – yellow sticks), and magenta ribbons for 
regions found to be mobile in 100 ns MD simulation. SARS 3CLpro inhibitor shown as grey 
sticks. 
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Apart from the more stable N- and C-termini for both subunits which form part of the dimer 
interface the remainder of the dimer remains of similar overall flexibility. One major 
difference is that in the dimeric form the loop 44CTSEDMLNPN53 which forms the boundary 
of the S2-subsite which binds bulky substrate residues Met/Phe/Leu is much less mobile than 
was seen in the 100ns simulation of the monomer. 
 
Moderately mobile regions (>1.5 RMSD) Chain A: loop Thr45-Asp48, a-helix Asn53-
Arg60, loop tip Asn72, loop tip Tyr154, strand Ala191-Ala193, strand residue Phe223, strand 
Asn274-Gly278, C-terminus Gly302-Gln306. Chain B: b-hairpin loop Gly23-Thr24, large 
loop Cys44-Asp53, strand Ile59-His64, loop tip Asn72, loop tip Tyr154, long strand and loop 
Val186-Gly195, strand residue Gly215, strand Phe223-Thr224, a-helical turn Leu232-
Tyr237, helix residue Val247, helical turn Ala255-Gly258, very mobile loop and helical turn 
Glu270-Leu286, C-terminus Gly302-Gln306 
 
